Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for drug or radiation exposure-related interstitial lung disease has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for drug or radiation exposure-related interstitial lung disease.
210 publications have been identified in PubMed for drug or radiation exposure-related interstitial lung disease. Research spans Review / Meta-Analysis (50%), Basic Science / Preclinical (23%), and Gene Therapy / Novel Therapeutics (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 104 | 50% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:26 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
49 |
23% |
New treatment approaches | 26 | 12% |
Disease patterns and progression | 15 | 7% |
Clinical study results | 8 | 4% |
Other research | 4 | 2% |
Testing and diagnosis research | 4 | 2% |
Guo D (2026). [PMID: 41797057](https://pubmed.ncbi.nlm.nih.gov/41797057/). *Drug Resist Updat*. [Review / Meta-Analysis]
Duncan FE (2026). [PMID: 41643029](https://pubmed.ncbi.nlm.nih.gov/41643029/). *Science*. [Other]
Tian Q (2026). [PMID: 42149294](https://pubmed.ncbi.nlm.nih.gov/42149294/). *J Egypt Natl Canc Inst*. [Review / Meta-Analysis]
Fu S (2026). [PMID: 41819735](https://pubmed.ncbi.nlm.nih.gov/41819735/). *Drug metabolism and disposition: the biological fate of chemicals*. [Basic Science / Preclinical]
Ren HC (2026). [PMID: 41412120](https://pubmed.ncbi.nlm.nih.gov/41412120/). *Expert Opin Drug Metab Toxicol*. [Review / Meta-Analysis]
Miyake T (2026). [PMID: 41780327](https://pubmed.ncbi.nlm.nih.gov/41780327/). *Drug Metab Pharmacokinet*. [Review / Meta-Analysis]
Drwiega EN (2026). [PMID: 42160195](https://pubmed.ncbi.nlm.nih.gov/42160195/). *Int J Pharm Pract*. [Epidemiology / Natural History]
Liu H (2026). [PMID: 41562582](https://pubmed.ncbi.nlm.nih.gov/41562582/). *Expert Opin Drug Discov*. [Review / Meta-Analysis]
Chen X (2026). [PMID: 41414871](https://pubmed.ncbi.nlm.nih.gov/41414871/). *Drug Deliv*. [Review / Meta-Analysis]
Zhao H (2026). [PMID: 41558570](https://pubmed.ncbi.nlm.nih.gov/41558570/). *Biochimie*. [Review / Meta-Analysis]